Financials data is unavailable for this security.
View more
Year on year Shanghai Allist Pharmaceuticals Co Ltd grew revenues 155.14% from 791.00m to 2.02bn while net income improved 393.54% from 130.52m to 644.17m.
Gross margin | 94.47% |
---|---|
Net profit margin | 38.37% |
Operating margin | 40.42% |
Return on assets | 25.24% |
---|---|
Return on equity | 27.50% |
Return on investment | 27.43% |
More ▼
Cash flow in CNYView more
In 2023, Shanghai Allist Pharmaceuticals Co Ltd increased its cash reserves by 244.40%, or 769.55m. The company earned 674.65m from its operations for a Cash Flow Margin of 33.43%. In addition the company generated 92.75m cash from investing, though they paid out 2.21m more in financing than they received.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 10.03 |
---|---|
Tangible book value per share | 9.88 |
More ▼
Balance sheet in CNYView more
Current ratio | 7.97 |
---|---|
Quick ratio | 7.88 |
Total debt/total equity | 0.0003 |
---|---|
Total debt/total capital | 0.0003 |
More ▼